Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Nemera
Nemera
Activities:
Drug Delivery
Medical Devices
Pharmaceutical
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
LUNA 3: Rilzabrutinib Phase III immune thrombocytopenia trial meets primary endpoint
Rilzabrutinib met both the primary endpoint of durable platelet response and various secondary endpoints in patients who were refractory to prior therapy
Memel Biotech and Therabest collaborate to develop exosome-based cell therapies
The partnership will aim to develop, manufacture and distribute novel exosome cell therapies in a range of therapeutic areas
Ipsen and Skyhawk Therapeutics partner to develop RNA-targeting drug candidates
The USD $1.8bn deal will support the development of novel RNA-modulating drugs using Skyhawk's proprietary technology
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Drug Delivery
Cristalia products with Nemera’s reusable pen injector commercialised in Brazil
Cristalia’s human growth hormone will be administered with CRISPEN, a pen injector designed by Nemera
Manufacturing
Nemera extends manufacturing capabilities in North America
With a newly acquired space in Vernon Hills, Nemera has opened a third location in the US, in addition to the manufacturing facility in Buffalo Grove and Innovation Center in Chicago
Manufacturing
Nemera's manufacturing facility inaugurated in Poland
The total area of the new site covers over 11,000 square metres including a 3,400 square metres clean room space
Finance
Nemera to build drug delivery device facility in Poland
The production plant is being built on an area of 5 hectares with dedicated expandable clean room space
Regulatory
Nemera updates branding and website
“We are thrilled to launch our new identity that re-unites our purpose of putting patients first and our commitment of being a holistic and agile partner”
Manufacturing
BIOMM to commercialise Nemera's reusable insulin pen
BIOMM will market the product under the trade name Lifepen in Brazil, where around 16.8 million people suffer from diabetes
Finance
Nemera to acquire Copernicus
The acquisition establishes Nemera’s operations footprint in Eastern Europe.
Subscribe now